2 results
Approved WMORecruiting
To investigate whether tPRF has an effect on the specific tumor marker of a specific tumor type in a patient with advanced cancer.
Approved WMOCompleted
To assess if short antibiotic treatment (3x24 hours) with an anti-pseudomonal carbapenem (imipenem-cilastatin or meropenem) is safe (NON-INFERIOR) with regard to treatment failure in comparison with extended treatment (at least 9x24hours) of high-…